A month in, TrumpRx falls short of president’s grand promises
statnews.com • • business
Key Points:
- President Trump launched TrumpRx as a transformative drug discount platform promising unprecedented medication cost cuts, but a month after launch, only 44 drugs are listed—mostly generics—and usage data remains undisclosed.
- Agreements between the White House and pharmaceutical companies are still being finalized, with major firms like Pfizer offering fewer drugs than initially expected, limiting the platform’s impact on drug prices for most patients.
- TrumpRx has provided meaningful discounts on select high-cost drugs, such as fertility medications, which could benefit patients paying out-of-pocket, but overall, experts say the program will make only a small dent in drug costs.
- Despite administration claims of millions of users and widespread impact, independent web traffic and search data suggest declining interest, and officials
